On Friday, Rani Therapeutics Holdings Inc (NASDAQ: RANI) opened higher 5.84% from the last session, before settling in for the closing price of $1.54. Price fluctuations for RANI have ranged from $0.39 to $3.87 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.78%. Company’s average yearly earnings per share was noted 59.52% at the time writing. With a float of $89.72 million, this company’s outstanding shares have now reached $97.54 million.
Rani Therapeutics Holdings Inc (RANI) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rani Therapeutics Holdings Inc is 8.02%, while institutional ownership is 16.13%. The most recent insider transaction that took place on Oct 23 ’25, was worth 1,260,417. In this transaction Director of this company bought 2,083,334 shares at a rate of $0.60, taking the stock ownership to the 2,083,334 shares. Before that another transaction happened on Oct 21 ’25, when Company’s 10% Owner sold 4,000,000 for $2.77, making the entire transaction worth $11,074,000. This insider now owns 2,379,194 shares in total.
Rani Therapeutics Holdings Inc (RANI) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 59.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Check out the current performance indicators for Rani Therapeutics Holdings Inc (RANI). In the past quarter, the stock posted a quick ratio of 0.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 165.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Compared to the last year’s volume of 5.85 million, its volume of 3.01 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 12.34%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 35.69%, which indicates a significant increase from 14.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2785 in the past 14 days, which was higher than the 0.1551 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2710, while its 200-day Moving Average is $0.9833. Nevertheless, the first resistance level for the watch stands at $1.7300 in the near term. At $1.8300, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9650. If the price goes on to break the first support level at $1.4950, it is likely to go to the next support level at $1.3600. Now, if the price goes above the second support level, the third support stands at $1.2600.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
There are currently 121,512K shares outstanding in the company with a market cap of 198.06 million. Presently, the company’s annual sales total 1,030 K according to its annual income of -30,020 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,690 K.
